article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

Founder: Graham Gardner Year of Establishment: 2010 Headquarters: Boston, Massachusetts. Founder: Grant Verstandig Year of establishment: 2010 Headquarters: Washington, DC. Founder: Jeff Tangney Year of establishment: 2010 Headquarters: San Francisco, California. In doing so, it helps to make each cancer patient’s story count.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biopharma could reap benefits from SVB UK acquisition

European Pharmaceutical Review

billion in total venture financing raised from 2010 to 2022 for drug development In 2018 alone, the company invested over $400 million in venture financing. However, the acquisition of Silicon Valley Bank UK by HSBC could provide greater access for biopharmaceutical startups to international markets and global networks of investors.

article thumbnail

Mass spectrometry software can link different data types

European Pharmaceutical Review

The second generation of MZmine, released in 2010, could process hundreds of samples over several days. Schmid shared with EPR the key features of the software: FAIR principles – each analysis is reproducible and fully described by the user parameters and input data. The release of this version enabled the project to be more widely known.

article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

Since 2010, the UK has fallen from 4th to 98th place in overall trade balance in pharmaceuticals, due to fierce global competition, according to the MMIP. Over the same period, similar countries – including Ireland, France, and Germany – have been moving to boosting manufacturing productivity, output, and exports.

article thumbnail

Journal Citation Reports 2022: A preview

Clarivate

Each year, the Journal Citation Reports (JCR) release provides a summary of the network of scholarly citations from the prior year of Web of Science coverage. Looking at the year-to-year changes in JIF from 2010 to 2021 (see Figure 1) highlights how unusual the 2020 data were in the context of both prior year, and of the coming year.

article thumbnail

Are timely access and robust safety mutually exclusive?

pharmaphorum

A new cross-sectional study has found that the FDA green lit 95% of the 89 new oncology therapies approved between 2010 and 2019 before the EMA, with the Europeans trailing the Americans by a median of 241 days. But while the figures may sound stark, they come as no surprise to the industry.

Safety 98